BeStock  
Markets › Compare › MIRM vs CORT

MIRM vs CORT

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
MIRM · Mirum Pharmaceuticals$96.13 ▲ 0.65%
CORT · Corcept Therapeutics$63.62 ▼ 2.09%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

3371110148186Nov 24, '25May 26, '26Nov 20, '26
  • MIRM +33.1%
  • CORT -18.1%

Head to head

MetricMIRMCORT
Price$96.13$63.62
Change today▲ 0.65%▼ 2.09%
Market cap$6.28B$6.96B
Return, 3 months-0.6%-48.4%
Return, year to date+21.7%+82.8%
Return, 1 year+35.5%-17.7%
P/E (TTM)–47.8
P/B-115.88.4
P/E percentile vs own 5y80th69th
Dividend yield––
Revenue growth (YoY, latest qtr)+39.6%+64.0%
Net profit growth (YoY)-1,503.3%+544.6%
Gross margin81.7%98.5%
Operating margin-21.6%11.5%
Net margin-134.8%16.5%
Return on equity-760.0%21.7%
Analyst target vs. price+65.2%+161.4%
Analyst buy share100%100%
RSI (14)6321
30-day volatility49.7%78.5%
Max drawdown, 1 year-38.4%-63.5%
Trend readLeaning bullishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CORT is the largest of the group by market value.
  • MIRM has returned the most over the past year.
  • CORT is growing revenue fastest.
  • CORT keeps the most profit per dollar of sales.
  • MIRM has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top